P

Priothera

0 followers

Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.

Headquarters

Dublin, Ireland

Employees

11-50

Links

Org chart

Florent Gros' profile picture
Florent Gros
CEO & Founder
Profile photo

Florent Gros

Collapse
Elisabeth Kueenburg's profile picture
Elisabeth Kueenburg
Chief Medical Officer
Stephan Oehen's profile picture
Stephan Oehen
Chief Operating Officer & Founder
Philippe Lievre's profile picture
Philippe Lievre
Chief Business Officer & Founder
Brice Suire's profile picture
Brice Suire
Chief Financial Officer & Founder
Karen Von Graevenitz's profile picture
Karen Von Graevenitz
Head of Regulatory Affairs
Simone Dertschnig's profile picture
Simone Dertschnig
Head of Research
Frédéric David
Head Technical Development
  1. Something went wrong loading the org chart, please refresh the page.